Coherus BioSciences
CHRS
#8193
Rank
HK$1.95 B
Marketcap
HK$13.06
Share price
-1.19%
Change (1 day)
50.07%
Change (1 year)

Market capitalization of Coherus BioSciences (CHRS)

Market cap: HK$1.95 Billion

As of February 2026 Coherus BioSciences has a market cap of HK$1.95 Billion. This makes Coherus BioSciences the world's 8193th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Coherus BioSciences from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$1.95 B56.12%
2025HK$1.25 B-6.15%
2024HK$1.33 B-53.98%
2023HK$2.89 B-39.82%
2022HK$4.81 B-49.63%
2021HK$9.55 B-1.56%
2020HK$9.70 B-1.62%
2019HK$9.86 B103.84%
2018HK$4.84 B19.9%
2017HK$4.03 B-57.63%
2016HK$9.52 B37.28%
2015HK$6.94 B64.88%
2014HK$4.20 B

End of Day market cap according to different sources

On Feb 26th, 2026 the market cap of Coherus BioSciences was reported to be:

HK$1.97 Billion
by Nasdaq info icon info icon
HK$1.97 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
HK$1.635 T 83,660.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$57.09 B 2,823.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
HK$6.42 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
HK$48.23 B 2,370.07%๐Ÿ‡บ๐Ÿ‡ธ USA